Growth Metrics

United Therapeutics (UTHR) Change in Acquisitions & Divestments (2016 - 2025)

United Therapeutics (UTHR) has disclosed Change in Acquisitions & Divestments for 17 consecutive years, with $485.5 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments changed N/A to $485.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.6 billion through Dec 2025, up 90.42% year-over-year, with the annual reading at $1.6 billion for FY2025, 90.42% up from the prior year.
  • Change in Acquisitions & Divestments hit $485.5 million in Q4 2025 for United Therapeutics, up from $182.5 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $1.6 billion in Q3 2023 to a low of -$955.9 million in Q4 2021.
  • Historically, Change in Acquisitions & Divestments has averaged $351.4 million across 5 years, with a median of $367.5 million in 2022.
  • Biggest YoY gain for Change in Acquisitions & Divestments was 7216.03% in 2021; the steepest drop was 6480.0% in 2021.
  • Year by year, Change in Acquisitions & Divestments stood at -$955.9 million in 2021, then skyrocketed by 206.47% to $1.0 billion in 2022, then tumbled by 48.25% to $526.7 million in 2023, then tumbled by 32.31% to $356.5 million in 2024, then surged by 36.19% to $485.5 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for UTHR at $485.5 million in Q4 2025, $182.5 million in Q3 2025, and $304.2 million in Q2 2025.